Trending

Sales and Marketing

Are pharma’s TV ad strategies out of date?

Are pharma’s TV ad strategies out of date?

TV viewing habits are changing dramatically, and these trends have only been accelerated by COVID-19 – but Intouch’s

X

Are pharma’s TV ad strategies out of date?

https://pharmaphorum.com/views-analysis-sales-marketing/are-pharmas-tv-ad-strategies-out-of-date/

A history of Pfizer

A history of Pfizer

In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart…

X

A history of Pfizer

https://pharmaphorum.com/sales-marketing/a_history_of_pfizer/

Online Live Team Pharma Forecasting Training Now Available

Online Live Team Pharma Forecasting Training Now Available

Working remotely can have its challenges, why not get together for a fun and rewarding learning experience and

X

Online Live Team Pharma Forecasting Training Now Available

https://pharmaphorum.com/events/online-pharma-forecasting-training/

VMLY&R creates global healthcare agency for innovative pharma companies

VMLY&R creates global healthcare agency for innovative pharma companies

Marketing agency VMLY&R has launched a new global healthcare agency, VMLY&Rx, to service specialty prescription pharmaceutical companies developing

X

VMLY&R creates global healthcare agency for innovative pharma companies

https://pharmaphorum.com/news/vmlyr-creates-global-healthcare-agency-for-innovative-pharma-companies/

Langland appoints Angela Rochelle to clinical trial diversity role

Langland appoints Angela Rochelle to clinical trial diversity role

Langland has announced the appointment of Angela Rochelle as account director, head of diversity initiatives in clinical trials.

X

Langland appoints Angela Rochelle to clinical trial diversity role

https://pharmaphorum.com/news/langland-appoints-angela-rochelle-to-clinical-trial-diversity-role/

The calm after the storm: How COVID-19 is making pharma more resilient

The calm after the storm: How COVID-19 is making pharma more resilient

COVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning

X

The calm after the storm: How COVID-19 is making pharma more resilient

https://pharmaphorum.com/views-analysis-sales-marketing/the-calm-after-the-storm-how-covid19-is-making-pharma-more-resilient-and-accessible/

Alliance and Boots donate dexamethasone to NHS

Alliance and Boots donate dexamethasone to NHS

The UK’s largest medical wholesaler and pharmacy have donated half a million dexamethasone tablets to support the effort

X

Alliance and Boots donate dexamethasone to NHS

https://pharmaphorum.com/news/alliance-and-boots-donates-dexamethasone-to-help-nhs-fight-covid-19/

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10

X

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

https://pharmaphorum.com/news/russian-sputnik-covid-19-vaccine-will-cost-less-than-10-a-dose/

FDA approves Roche’s Xofluza to prevent flu spreading in families

FDA approves Roche’s Xofluza to prevent flu spreading in families

The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people

X

FDA approves Roche’s Xofluza to prevent flu spreading in families

https://pharmaphorum.com/news/fda-approves-roches-xofluza-to-prevent-flu-spreading-in-families/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com